Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

It's time for us to pass this cost back to Big Pharma where it belongs,” Commissioner Cameron Davis said. “It's also time to not keep the burden on the shoulders of our taxpayers.” ...

Using money from the opioid settlement funds from big pharmaceutical companies, St. Johns County will partner with EPIC ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Kim Gillan writes, As the 119th Congress gets to work, I’m hopeful that Montana’s Congressional Delegation will prioritize and support legislation that addresses the ever-growing cost of prescription ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified wha ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...